How often does Heron Therapeutics move more than the options market prices?

3 of the last 8 reports moved at least as far as the implied move.

HRTXNasdaqPharmaceutical Preparations

Heron Therapeutics, Inc. (HRTX) earnings date, market-implied expected move, and options open interest by expiry

0.29

+0.01 · +3.58%

Regular session14:48 ET

Open0.30Volume1.0MMkt cap$54.1MEPS-0.19

Day0.29 – 0.3023%52-wk0.26 – 1.583%

HRTX

Heron Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 9

before open · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

−31.74%

vs ±62.0% implied · ×0.51

shaded = implied · ▲▼ = realized

Aug 10 '26 · confirmed

Implied vs realized

Largest filed tie

filed ties

13F top-10 QoQ

−3.67%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

162 managers

Top fund weight

0.00%

HRTX weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Heron Therapeutics (HRTX) is expected to report on Nov 9 before open (estimated date).

Implied vs realized

8 reports

3 of 8≥ implied

avg implied: ±29.8%
avg realized: ±19.9%

Nov 12 '24Nov 12 '24confirmed±20.4%▼−30.43%×1.50

Feb 27 '25Feb 27 '25confirmed±16.1%▲+19.88%×1.24

May 6 '25May 6 '25confirmed±21.3%▲+13.62%×0.64

Aug 8 '25Aug 8 '25confirmed±26.7%▼−28.26%×1.06

Q3 FY25Nov 4 '25confirmed±24.3%▼−3.39%×0.14

Q1 FY26Feb 26 '26confirmed±34.8%▲+11.11%×0.32

May 11 '26May 11 '26confirmed±32.7%▼−21.05%×0.64

Q2 FY26Aug 10 '26confirmed±62.0%▼−31.74%×0.51

quarterimplied−65%0+65%realized×

Q2 FY26±62.0%▼−31.74%×0.51

May '26±32.7%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 3 close

—OI · 3 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

20,9820%Nov 2016d0—

2160%Dec 1844d0.054,613+3%0.05

10%Mar 19135d0.001,9620%0.00

ExpiryPutsCallsP/C

Nov 2016d20,9820%0——

Dec 1844d2160%4,613+3%0.05

Mar 19135d10%1,9620%0.00

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−14.57%as filednet margin · revenue +8.51% QoQ · +1.25% YoY

Revenue$38M+8.51%

Gross profit$26M69.28%+8.40%

Operating income−$2M−5.43%+57.10%

Pre-tax income−$5M+32.33%

Net income−$5M−14.57%+32.33%

Cost of revenue$12M+8.78%

Operating expenses$28M−2.43%

Other expense−$3M−2.96%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 14:45 ET

Intraday

Event sensitivity

NFP ×1.31· ±4.9% vs ±3.8% · 10 releases

eventrelease day|move|up · n×base

NFPjobs report±4.9%3 of 10×1.31

GDPgross domestic product±3.5%10 of 19×0.93

PCEpersonal income & outlays±3.1%5 of 19×0.82

FOMCrate decision±2.7%10 of 24×0.73

CPROFcorporate profits±2.5%5 of 12×0.67

PPIproducer prices±2.2%3 of 10×0.59

CPIconsumer prices±2.0%6 of 10×0.54

Bar = avg |move| to ±5% · tick = ±3.8% avg day · ×base = |move| ÷ ±3.8% · min 6 releases

Earnings history

EPS -0.03 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 10 '26 · confirmed	-0.03	—
Q1 FY26	Feb 26 '26 · confirmed	-0.04	—
Q3 FY25	Nov 4 '25 · confirmed	-0.10	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod